Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Palumbo

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Blood|December 27, 2021
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNALih Jiin Juang, Woosuk S Hur, Lakmali M Silva, et al.
Cell|November 23, 2023
S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axisLiwen Deng, Flavia Costa, Kimbria J Blake, et al.
Blood Advances|October 1, 2020
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)Katharina Thom, Anthonie W A Lensing, Ildar Nurmeev, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
European Journal of Preventive Cardiology|July 22, 2025
Refining current risk stratification guidelines for pregnant women with Fontan circulation: lessons from PROFAT registryMagalie Ladouceur, Andrea Girnius, Dominica Zentner, et al.
The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Blood|December 27, 2021
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNALih Jiin Juang, Woosuk S Hur, Lakmali M Silva, et al.
Cell|November 23, 2023
S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axisLiwen Deng, Flavia Costa, Kimbria J Blake, et al.
Blood Advances|October 1, 2020
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)Katharina Thom, Anthonie W A Lensing, Ildar Nurmeev, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
European Journal of Preventive Cardiology|July 22, 2025
Refining current risk stratification guidelines for pregnant women with Fontan circulation: lessons from PROFAT registryMagalie Ladouceur, Andrea Girnius, Dominica Zentner, et al.
The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Pageof 16